RGLS Stock | | | USD 1.64 0.07 4.46% |
Regulus Therapeutics financial indicator trend analysis is much more than just breaking down Regulus Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Regulus Therapeutics is a good investment. Please check the relationship between Regulus Therapeutics Cash Per Share and its Capex To Operating Cash Flow accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regulus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of economic analysis.
For more information on how to buy Regulus Stock please use our
How to Invest in Regulus Therapeutics guide.
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Regulus Therapeutics Cash Per Share account and
Capex To Operating Cash Flow. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Regulus Therapeutics' Cash Per Share and Capex To Operating Cash Flow is 0.5. Overlapping area represents the amount of variation of Cash Per Share that can explain the historical movement of Capex To Operating Cash Flow in the same time period over historical financial statements of Regulus Therapeutics, assuming nothing else is changed. The correlation between historical values of Regulus Therapeutics' Cash Per Share and Capex To Operating Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash Per Share of Regulus Therapeutics are associated (or correlated) with its Capex To Operating Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Operating Cash Flow has no effect on the direction of Cash Per Share i.e., Regulus Therapeutics' Cash Per Share and Capex To Operating Cash Flow go up and down completely randomly.
Correlation Coefficient | 0.5 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Most indicators from Regulus Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Regulus Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regulus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of economic analysis.
For more information on how to buy Regulus Stock please use our
How to Invest in Regulus Therapeutics guide.At this time, Regulus Therapeutics'
Tax Provision is comparatively stable compared to the past year.
Issuance Of Capital Stock is likely to gain to about 18
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 9.4
M in 2024.
When running Regulus Therapeutics' price analysis, check to
measure Regulus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regulus Therapeutics is operating at the current time. Most of Regulus Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Regulus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regulus Therapeutics' price. Additionally, you may evaluate how the addition of Regulus Therapeutics to your portfolios can decrease your overall portfolio volatility.